![Michael Teifel](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michael Teifel
Hoofd Techniek/Wetenschap/O&O bij
CEAPRO INC.
Vermogen: - $ op 31-05-2026
Profiel
Michael Teifel was the founder of Munich Biotech AG, founded in 1998, where the title held was Head-Pharmacology & Toxicology from 1998 to 2004.
Current jobs include Chief Scientific Officer & Senior Vice President at COSCIENS Biopharma, Inc. since 2021, and Chief Scientific Officer & SVP-Clinical at Ceapro, Inc. Former jobs include Vice President-Non Clinical Services at Aeterna Zentaris GmbH from 2014 to 2019, Vice President-Non Clinical Sciences at Æterna Zentaris, Inc. from 2014 to 2021, and Head-Translational Sciences at Cleara Biotech BV.
Education includes a doctorate from Technische Universität Darmstadt conferred in 1996.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
-.--% | 31-12-2025 | 0 ( -.--% ) | - $ | 31-05-2026 |
Actieve functies van Michael Teifel
| Bedrijven | Functie | Begin |
|---|---|---|
| CEAPRO INC. | Hoofd Techniek/Wetenschap/O&O | - |
Eerdere bekende functies van Michael Teifel
| Bedrijven | Functie | Einde |
|---|---|---|
AEterna Zentaris GmbH
 AEterna Zentaris GmbH Miscellaneous Commercial ServicesCommercial Services Engages in biopharmaceutical research specializing in oncology and endocrinology | Corporate Officer/Principal | 01-10-2019 |
Munich Biotech AG
 Munich Biotech AG Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals | Oprichter | 01-08-2004 |
Cleara Biotech BV
 Cleara Biotech BV Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Corporate Officer/Principal | - |
Æterna Zentaris, Inc.
 Æterna Zentaris, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes pharmaceutical products for diagnosis of adult growth hormone deficiency | Hoofd Techniek/Wetenschap/O&O | - |
Opleiding van Michael Teifel
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
26
Eerstegraads connecties
6
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 6 |
|---|---|
Æterna Zentaris, Inc.
Æterna Zentaris, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes pharmaceutical products for diagnosis of adult growth hormone deficiency | Health Technology |
Ceapro, Inc.
 Ceapro, Inc. BiotechnologyHealth Technology Develops and commercializes active ingredients and anti-aging products for for healthcare and cosmetic industries | Health Technology |
Munich Biotech AG
Munich Biotech AG Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals | Health Technology |
Technische Universität Darmstadt
 Technische Universität Darmstadt Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
AEterna Zentaris GmbH
AEterna Zentaris GmbH Miscellaneous Commercial ServicesCommercial Services Engages in biopharmaceutical research specializing in oncology and endocrinology | Commercial Services |
Cleara Biotech BV
Cleara Biotech BV Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Kies MarketScreener 
